These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38689171)

  • 21. [The significance of arterial chemotherapy for multiple hepatic metastases from colorectal carcinoma].
    Matsumoto J; Minami T; Takahashi N; Takanishi K; Matsumine T
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1696-8. PubMed ID: 9382509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer].
    Shitara K; Munakata M; Kudo T; Kasai M; Muto O; Okada R; Mitobe S; Ishiguro A; Sakuraba H; Ikami I; Sakata Y
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2033-7. PubMed ID: 17197748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role for hepatic-directed chemotherapy in colorectal liver metastases.
    Ensminger WD
    J Clin Oncol; 2005 Aug; 23(22):4815-7. PubMed ID: 16009957
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of liver metastases of colorectal cancer.
    Rothbarth J; van de Velde CJ
    Ann Oncol; 2005; 16 Suppl 2():ii144-9. PubMed ID: 15958446
    [No Abstract]   [Full Text] [Related]  

  • 25. Outcomes of a Phase I/II Trial of Hepatic Arterial Infusion of Oxaliplatin Combined with Intravenous 5-Fluorouracil and l-Leucovorin in Patients with Unresectable Liver Metastases from Colorectal Cancer After Systemic Chemotherapy Failure.
    Sato Y; Inaba Y; Ura T; Nishiofuku H; Yamaura H; Kato M; Takahari D; Tanaka T; Muro K
    J Gastrointest Cancer; 2018 Jun; 49(2):132-137. PubMed ID: 28058527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
    Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
    Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is thymidylate synthase a reliable predictor for response and survival during hepatic arterial infusion for hepatic metastases from colorectal cancer?
    Ferretti G; Alimonti A; Cognetti F
    Br J Cancer; 2006 Nov; 95(9):1304-5; author reply 1306-7. PubMed ID: 17043683
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatic arterial infusion: the beginning of the combination era.
    Pestalozzi BC; Gruttadauria S; Clavien PA
    J Clin Oncol; 2008 May; 26(13):2231-2; author reply 2232-3. PubMed ID: 18445857
    [No Abstract]   [Full Text] [Related]  

  • 29. [A study of regional chemotherapy: hepatic arterial infusion for metastatic liver tumors].
    Takahashi T; Misuta K; Masui H; Ike H; Ohki S; Shimada H
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2155-7. PubMed ID: 7944427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
    Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
    Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
    Pak LM; Kemeny NE; Capanu M; Chou JF; Boucher T; Cercek A; Balachandran VP; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; D'Angelica MI
    J Surg Oncol; 2018 Mar; 117(4):634-643. PubMed ID: 29165816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rules to carry out hepatic arterial infusion chemotherapy at home for patients with liver metastasis of colorectal cancer].
    Takahashi K; Mori T; Yamaguchi T; Honma S; Arai K; Iwasaki Y; Kimura Y
    Gan To Kagaku Ryoho; 2002 Dec; 29 Suppl 3():480-3. PubMed ID: 12536834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of complete pathologic response and hepatic injuries between hepatic arterial infusion and systemic administration of oxaliplatin in patients with colorectal liver metastases.
    Allard MA; Sebagh M; Baillie G; Lemoine A; Dartigues P; Faitot F; Faron M; Boige V; Vitadello F; Vibert E; Elias D; Adam R; Goéré D; Sa Cunha A
    Ann Surg Oncol; 2015; 22(6):1925-32. PubMed ID: 25448804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
    Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
    Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-Arterial Therapy for Unresectable Colorectal Liver Metastases: Which and When? A Commentary on "Intra-Arterial Therapy for Unresectable Colorectal Liver Metastases: A Meta-Analysis".
    Sofocleous CT; D'Angelica MI
    J Vasc Interv Radiol; 2021 Nov; 32(11):1546-1547. PubMed ID: 34717833
    [No Abstract]   [Full Text] [Related]  

  • 36. Arterial, portal, or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma.
    Kemeny N; Fata F
    J Hepatobiliary Pancreat Surg; 1999; 6(1):39-49. PubMed ID: 10436236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.
    Lévi FA; Boige V; Hebbar M; Smith D; Lepère C; Focan C; Karaboué A; Guimbaud R; Carvalho C; Tumolo S; Innominato P; Ajavon Y; Truant S; Castaing D; De Baere T; Kunstlinger F; Bouchahda M; Afshar M; Rougier P; Adam R; Ducreux M;
    Ann Oncol; 2016 Feb; 27(2):267-74. PubMed ID: 26578731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The present and future of home care chemotherapy for patients with advanced and recurrent colorectal cancer].
    Takahashi K; Mori T; Yamaguchi T; Matsumoto H; Miyamoto H; Arai K; Iwasaki Y; Katayanagi S
    Gan To Kagaku Ryoho; 2004 Dec; 31 Suppl 2():154-6. PubMed ID: 15645757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic artery infusion for unresectable colorectal cancer liver metastases: Palliation and conversion.
    Zaidi MY; Nussbaum DP; Hsu SD; Strickler JH; Uronis HE; Zani S; Allen PJ; Lidsky ME
    Surgery; 2023 Aug; 174(2):428-430. PubMed ID: 37183130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of hepatic resection following hepatic arterial infusion chemotherapy for colorectal liver metastases].
    Tono T; Takahashi H; Nakano Y; Matsushita M; Ohzato H; Fukunaga M; Watanabe H; Kanoh Y; Yasue A; Okada K; Hata T; Iwazawa T; Matsui S; Yano H; Kinuta M; Okamura J; Monden T
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1826-9. PubMed ID: 11086422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.